ReviewFrontiers in bioengineering and biotechnology2025
Hydrogels as a new platform of therapeutic systems in oncological treatment - use as a protective barrier and drug carriers.
Review in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Nature to Nanomedicine: Engineered Plant-Derived Nanovesicles for Skin Disease.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrogels as three-dimensional polymer networks capable of reversibly absorbing water are of increasing interest among researchers. Hydrogels, especially those of natural origin such as alginate, chitosan, hyaluronic acid, peptide hydrogels, thanks to properties such as biocompatibility, biodegradability, bioactivity, can serve as an effective protective barrier or drug carrier. Thanks to the possibility of their modification, they can be an innovative platform supporting anticancer treatment. The examples presented in this publication confirm that these products can increase the effectiveness of treatment and reduce the effects of side effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.